Osstell

Osstell awarded innovation and development grant from VINNOVA

Press Release   •   Nov 08, 2013 15:06 GMT

With more than 300 applicants, Osstell has once more shown sustainable growth and commitment to clinical research to be awarded an innovation and development grant from VINNOVA, the Swedish Innovation Agency. The awarded project aims to further develop Osstell’s patented ISQ (Implant Stability Quotient) technology.  ISQ measures dental implant stability by taking the highest and lowest stability values which enables the clinician to make an assessment on when to load and restore the patients implant, or how to continue the patient’s treatment. The implant’s stability is currently assessed by two or more ISQ measurements in different directions. The new technique will allow the clinician to make a more clinically informed decision by presenting additional data (directional implant stability) with one single measurement. Furthermore, this will improve treatment recovery times and hence reduce costs of care – an important evaluation and selection criteria for VINNOVA. 

For more information, please contact:
Jonas Ehinger
President and Managing Director
Osstell AB
E-mail jonas.ehinger@osstell.com
Tel +46 (0)31 340 8250


Osstell specializes in instruments for analyzing dental implant stability. Osstell ISQ measures the stability of implants in an objective, non-invasive manner using the universal ISQ scale (Implant Stability Quotient). The ISQ values help dentists determine the optimal time to load each implant. By detecting decreasing stability, Osstell ISQ can also help prevent failures caused by pre-mature loading. Over 500 studies and ten years of clinical experience around the world confirm the usefulness of Osstell ISQ for dentists and surgeons.